Evidence map›Paper›PMID 26094554›Full record

ArticleTissue engineering. Part A2015

Functional Reconstruction of Tracheal Defects by Protein-Loaded, Cell-Seeded, Fibrous Constructs in Rabbits.

Lindsey M Ott, Cindy H Vu, Ashley L Farris, Katrina D Fox, Richard A Galbraith, Mark L Weiss, Robert A Weatherly, Michael S Detamore

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. [Intraoperative treatment plan for cervical tracheal defect].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lindsey M Ott1 Bioengineering Program, University of Kansas , Lawrence, Kansas.
Cindy H Vu2 School of Medicine, University of Kansas , Kansas City, Kansas.
Ashley L Farris3 Department of Molecular Biosciences, University of Kansas , Lawrence, Kansas.
Katrina D Fox4 College of Veterinary Medicine, Kansas State University , Manhattan, Kansas.
Richard A Galbraith5 Anatomic and Clinical Pathology, Lawrence Memorial Hospital , Lawrence, Kansas.
Mark L Weiss4 College of Veterinary Medicine, Kansas State University , Manhattan, Kansas.
Robert A Weatherly6 Section of Otolaryngology, Children's Mercy Hospital , Kansas City, Missouri.
Michael S Detamore1 Bioengineering Program, University of Kansas , Lawrence, Kansas.
University of Kansas · USKansas State University · US

Funding

PHARMACEUTICAL ASPECTS OF BIOTECHNOLOGY TRAININGT32GM008359 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI SIAHAAN, TERUNA J., VOLKIN, DAVID · 1989 to 2018
$5.0M
NIGMS NIH HHS T32 GM008359
6 · The paper itself

Abstract

Tracheal stenosis is a life-threatening disease and current treatments include surgical reconstruction with autologous rib cartilage and the highly complex slide tracheoplasty surgical technique. We propose using a sustainable implant, composed of a tunable, fibrous scaffold with encapsulated chondrogenic growth factor (transforming growth factor-beta3 [TGF-β3]) or seeded allogeneic rabbit bone marrow mesenchymal stromal cells (BMSCs). In vivo functionality of these constructs was determined by implanting them in induced tracheal defects in rabbits for 6 or 12 weeks. The scaffolds maintained functional airways in a majority of the cases, with the BMSC-seeded group having an improved survival rate and the Scaffold-only group having a higher occurrence of more patent airways as determined by microcomputed tomography. The BMSC group had a greater accumulation of inflammatory cells over the graft, while also exhibiting normal epithelium, subepithelium, and cartilage formation. Overall, it was concluded that a simple, acellular scaffold is a viable option for tracheal tissue engineering, with the intraoperative addition of cells being an optional variation to the scaffolds.

Indexed as

AnimalsBronchoscopyCollagenImage Processing, Computer-AssistedInflammationMaleNeovascularization, PhysiologicRabbitsSurvival AnalysisTissue ScaffoldsTracheaTransforming Growth Factor beta3X-Ray MicrotomographyCollagenTransforming Growth Factor beta3

Identifiers

PMID26094554
PMCPMC4555647
OpenAlexW1658823683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.